When PERK inhibitors turn out to be new potent RIPK1 inhibitors: critical issues on the specificity and use of GSK2606414 and GSK2656157

Diego Rojas‐Rivera(Universidad Mayor), Mathieu J.M. Bertrand(Ghent University)
Cell Death and Differentiation
April 28, 2017
Cited by 198


Related Papers